3-Diethylamino-2,2-dimethyl-propionaldehyde, 95.0%, 1g

Methyl 6-chloro-3-(trifluoromethyl)picolinate, 95.0%, 1g

(1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl Succinimidyl Carbonate (2mg*5)1set

(4-Nitrophenyl)methanesulfonyl chloride, 95.0%, 1g

N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide, 98%, 25mg

Fmoc-N-(allyl)-glycine, 99.0%, 250mg

2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 95%, 10g

5-Phenyl-o-toluidine, 98.0%, 1g

4-Methyl-3-nitrobenzyl Alcohol>96.0%(GC)5g

Ethyl 4-[5-(trifluoromethyl)pyridin-2-yl]benzoate, 95.0%, 1g

3-(4-bromo-1H-pyrazol-1-yl)propan-1-ol, 95.0%, 1g

2,3,4-Trifluorobenzoyl Chloride>98.0%(T)5g

GC capillary column ROTI®Cap-1701, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)